Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextenza in Clinically Significant Dry Eye
NCT04498468Phase 4Terminated
- Sponsor
- Johns Hopkins University
- Start
- Mar 2021
- Primary completion
- Mar 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone in dry eye syndrome (DED), sponsored by Johns Hopkins University. Started Mar 2021; status: terminated.
02
Drugs
dexamethasone
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT04498468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04498468.